ClinicalTrials.gg
Sign In

Rhinosinusitis clinical trials

The registry lists 251 studies for Rhinosinusitis across more than 10 countries. 69 are recruiting or about to start. 146 of them are mainly about Rhinosinusitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Rhinosinusitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
123
Not yet recruiting
33
Recruiting
33
Status unknown
24
Active, not recruiting
13
Withdrawn
12

Phase

Phase 2
43
Phase 3
41
Phase 4
35
Phase 1
17
Early Phase 1
5

Where

United States
71
China
40
Canada
31
Germany
21
Egypt
15
Spain
14

Who runs them

Sanofi (11) · Cairo University (6) · Keymed Biosciences Co.Ltd (5) · AstraZeneca (5) · Beijing Tongren Hospital (5) · Washington University School of Medicine (4) · Centre hospitalier de l'Université de Montréal (CHUM) (4) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (3)

What is being tested here

Drugs under test in Rhinosinusitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Budesonide104
MMH-407111
Sodium Chloride002
Tezepelumab011
Dexmedetomidine001
Saline Solution001
Xylitol011
Acetylcysteine011
Dexpramipexole001
Silver001

Drug classes tested here Corticosteroids 1 open

Coming up

16phase 3 studies under way
30studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 33 Rhinosinusitis studies recruiting now, 14 (42%) set no upper age limit and 13 (39%) stop at 75 or younger. 4 (12%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 6 (18%) take healthy volunteers.

Recruiting studies that take each age, of 33
AgeWomenMen
100 (0%)0 (0%)
1830 (91%)30 (91%)
3032 (97%)32 (97%)
4032 (97%)32 (97%)
5032 (97%)32 (97%)
6529 (88%)29 (88%)
7524 (73%)24 (73%)
8518 (55%)18 (55%)

Across all 251 studies, recruiting or not: 43% stop at 75 or younger and 20% at 65; 16% take children; 0% are for women only and <1% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Rhinosinusitis studies take

Of 24 phase 3 interventional studies under Rhinosinusitis, half reached primary completion within 22 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 218 mo13–26 · 16 studies——
Phase 322 mo19–37 · 24 studies——
Phase 433 mo14–35 · 14 studies——
Interventional, no phase16 mo6–36 · 33 studies——
Observational27 mo15–71 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 251. Browse all 251 → or search them.